Skip to main content

Table 1 Baseline clinical and laboratory data of patients and control group.

From: Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study

  Obese children with IDA Non obese children with IDA Control P
  (n = 35) (n = 35) (n = 30)  
Age (years) 6.96 ± 2.2 7.11 ± 2.57 7.11 ± 2.57 >0.05
Male/female # 22/18 23/17 11/9 >0.05
BMI (kg/m2) 25.70 ± 2.2 a 16.30 ± 1.9 b 16.2 ± 1.7 b <0.05
Hb (g/dl) 8.82 ± 1.2 a 8.22 ± 1.4 a 13.0 ± 1.4 b <0.05
MCV (fl) 70.80 ±4.6 a 69.33 ± 4.0 a 92.33 ± 7.0 b <0.05
MCHC (%) 26.3 ± 2.3 a 25.6 ± 2.5 a 33.7 ± 2.6 b <0.05
Serum iron (ug/dl) 28.83 ± 2.5 a 29.28 ± 4.6 a 90.45 ± 4.4 b <0.05
TIBC (mg/dl) 491 ± 24 a 478 ± 15 a 258 ± 15 b <0.05
Transferrin saturation (%) 5.87 ± 0.9 a 6.13 ± 1.2 a 35.05 ± 1.7 b <0.05
Transferrin (umol/L) 75 ± 7.1 a 77 ± 6.8 a 34 ± 2.3 b <0.05
Ferritin (ng/ml) 51.91 ± 8.7 a 7.52 ± 1.6 b 56.19 ± 4.1 a <0.05
CRP (mg/dl) 5.71 ± 0.7 a 2.42 ± 0.5 b 2.53 ± 0.6 b <0.05
Serum hepcidin (nmol/l) 4.96 ± 1.2 a 0.11 ± 0.03 b 1.61 ± 0.7 c <0.05
  1. The P value is for ANOVA. a, b and c on means refer to significant difference between means when ANOVA test refers to significances by multiple comparison analysis (aa, bb, cc = non-significant, ab, ac, bc = significant). # Chi-square test.